# Health Economic Evaluation of Influenza and Pneumococcal Vaccination in COPD Patients

> **NCT07640841** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 7000 (estimated)

## Conditions studied

- Influenza and Pneumonia

## Interventions

- **BIOLOGICAL:** Influenza Vaccine Group
- **BIOLOGICAL:** Pneumococcal Vaccine Group

## Key facts

- **NCT ID:** NCT07640841
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 7000 (ESTIMATED)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640841, "Health Economic Evaluation of Influenza and Pneumococcal Vaccination in COPD Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07640841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*